These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31503303)

  • 1. Proposals to Lower Medication Costs.
    Cohen R; Levin JM; Maraganore JM
    JAMA; 2019 Sep; 322(10):982. PubMed ID: 31503303
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposals to Lower Medication Costs-Reply.
    Califf RM; Slavitt A
    JAMA; 2019 Sep; 322(10):982-983. PubMed ID: 31503306
    [No Abstract]   [Full Text] [Related]  

  • 3. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
    Sensharma A; Yabroff KR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):263-277. PubMed ID: 30628493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower your drug costs.
    Santa J
    Consum Rep; 2009 Jun; 74(6):13. PubMed ID: 19455768
    [No Abstract]   [Full Text] [Related]  

  • 5. State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2016 Jun; 374(24):2301-4. PubMed ID: 27305189
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prescription Drug Cost-Containment Debate: The Outcome Affects Us.
    Baldwin P
    Consult Pharm; 2018 Nov; 33(11):668. PubMed ID: 30458909
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-31. PubMed ID: 30695849
    [No Abstract]   [Full Text] [Related]  

  • 9. Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation.
    Califf RM; Slavitt A
    JAMA; 2019 Apr; 321(16):1571-1573. PubMed ID: 31012911
    [No Abstract]   [Full Text] [Related]  

  • 10. Business of Health. Business of Healthcare.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-60. PubMed ID: 30681304
    [No Abstract]   [Full Text] [Related]  

  • 11. The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts.
    Horvath JC; Anderson GF
    JAMA; 2019 Apr; 321(16):1561-1562. PubMed ID: 31012941
    [No Abstract]   [Full Text] [Related]  

  • 12. Specialty medications: traditional and novel tools can address rising spending on these costly drugs.
    Lotvin AM; Shrank WH; Singh SC; Falit BP; Brennan TA
    Health Aff (Millwood); 2014 Oct; 33(10):1736-44. PubMed ID: 25288417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considering transparency and value for fairer drug prices.
    Webster P
    CMAJ; 2018 Jan; 190(1):E30-E31. PubMed ID: 29311107
    [No Abstract]   [Full Text] [Related]  

  • 14. The Economics of Indication-Based Drug Pricing.
    Chandra A; Garthwaite C
    N Engl J Med; 2017 Jul; 377(2):103-106. PubMed ID: 28700848
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-related medication underuse: Strategies to improve medication adherence at care transitions.
    Miranda AC; Serag-Bolos ES; Cooper JB
    Am J Health Syst Pharm; 2019 Apr; 76(8):560-565. PubMed ID: 31361859
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten Tips to Help Outpatients Save Money.
    Greenberg J
    Am J Med; 2017 Mar; 130(3):283-284. PubMed ID: 27746289
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference.
    Greczyn RJ
    N C Med J; 2003; 64(6):285-6. PubMed ID: 14983619
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.
    Jacob L; Bohlken J; Kostev K
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):9-15. PubMed ID: 27879194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.